The drug development crisis: efficiency and safety.
Annu Rev Med
; 58: 1-16, 2007.
Article
en En
| MEDLINE
| ID: mdl-17059362
ABSTRACT
Despite advancements in genetics, chemistry, and protein engineering, recent years have seen fewer approvals of new drugs, increases in development costs, and high-profile drug withdrawals. This article focuses on technologic methods for improving drug development efficiency. These technologies include high-content cell screening, expression profiling, mass spectroscopy, mouse models of disease, and a post-launch screening program that enables investigations of adverse drug effects. Implementation of these new technologies promises to improve performance in drug development and safety.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ensayos Clínicos como Asunto
/
Aprobación de Drogas
/
Tecnología Biomédica
/
Evaluación Preclínica de Medicamentos
Límite:
Animals
/
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Annu Rev Med
Año:
2007
Tipo del documento:
Article
País de afiliación:
Estados Unidos